Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario Neri

Showing results (11-20 of 431) with videos related to

Pageof 44
Sort By:
Journal of Medicinal Chemistry|June 17, 2015
Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic AgentsGiulio Casi, Dario Neri
Advanced Drug Delivery Reviews|July 11, 2006
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosisEveline Trachsel, Dario Neri
Current Opinion in Chemical Biology|March 18, 2015
Dual-pharmacophore DNA-encoded chemical librariesJörg Scheuermann, Dario Neri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trendsMartina Steiner, Dario Neri
Nature Reviews. Cancer|June 2, 2005
Tumour vascular targetingDario Neri, Roy Bicknell
International Journal of Cancer|July 3, 2013
The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancerTeresa Hemmerle, Dario Neri
Cancer Immunology, Immunotherapy : CII|February 28, 2015
The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activityChristian Hess, Dario Neri
New Biotechnology|April 17, 2019
Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammationPatrizia Murer, Dario Neri
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
Calmodulin as an affinity purification tagSamu Melkko, Dario Neri
Cancer Immunology Research|May 6, 2014
The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivoTeresa Hemmerle, Dario Neri
Pageof 44

Showing results (11-20 of 431) with videos related to

Sort By:
Pageof 44
Journal of Medicinal Chemistry|June 17, 2015
Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic AgentsGiulio Casi, Dario Neri
Advanced Drug Delivery Reviews|July 11, 2006
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosisEveline Trachsel, Dario Neri
Current Opinion in Chemical Biology|March 18, 2015
Dual-pharmacophore DNA-encoded chemical librariesJörg Scheuermann, Dario Neri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trendsMartina Steiner, Dario Neri
Nature Reviews. Cancer|June 2, 2005
Tumour vascular targetingDario Neri, Roy Bicknell
International Journal of Cancer|July 3, 2013
The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancerTeresa Hemmerle, Dario Neri
Cancer Immunology, Immunotherapy : CII|February 28, 2015
The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activityChristian Hess, Dario Neri
New Biotechnology|April 17, 2019
Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammationPatrizia Murer, Dario Neri
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
Calmodulin as an affinity purification tagSamu Melkko, Dario Neri
Cancer Immunology Research|May 6, 2014
The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivoTeresa Hemmerle, Dario Neri
Pageof 44